Benitec BiopharmaBNTC
13F holders, Q1 2025 (March 31)37holders +7
9new positions
3sold out
1famous investor
$13.25avg. 13F price*
At the end of Q1 2025, 37 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings, up 7 from Q4 2024. 9 opened new positions and 3 sold out. The largest holders were Montanova Capital, LLC ($128.5M), Janus Henderson Group PLC ($39.0M) and Franklin Resources Inc. ($37.2M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Benitec Biopharma Inc.
- CUSIP
- 08205P209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $6.4M |
| Exits | 3 | $475K |
All 13F filers, Q4 2024 → Q1 2025: 2,956,879 shares bought and 141,593 shares sold, net +2,815,286 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Montanova Capital, LLC | 5.20% | Add +10.2% | 9,876,506 | $128.5M |
| Janus Henderson Group PLC | 0.02% | Add +11.6% | 2,918,950 | $39.0M |
| Franklin Resources Inc. | 0.01% | Reduce -2.7% | 2,860,726 | $37.2M |
| Adage Capital Partners Gp, L.L.C. | 0.05% | No change | 1,972,524 | $25.7M |
| Infinitum Asset Management, LLC | 6.05% | Add +435.7% | 1,125,000 | $18.9M |
| Nantahala Capital Management, LLC | 0.90% | No change | 838,095 | $10.9M |
| Vanguard Group Inc. | 0.00% | Add +9.0% | 327,034 | $4.3M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +0.5% | 261,764 | $3.4M |
| Silverarc Capital Management, LLC | 0.68% | New | 250,000 | $3.3M |
| Geode Capital Management, LLC | 0.00% | Add +18.6% | 233,820 | $3.0M |
| Susquehanna International Group, LLP | 0.00% | Add +812.7% | 226,096 | $2.9M |
| BlackRock, Inc. | 0.00% | Add +6.1% | 184,426 | $2.4M |
| AWM Investment Company, Inc. | 0.25% | Add +35.2% | 137,977 | $1.8M |
| ExodusPoint Capital Management, LP | 0.01% | New | 83,198 | $1.1M |
| Longaeva Partners L.P. | 0.64% | — | 80,000 | $1.0M |
| Simplify Asset Management Inc. | 0.05% | Add +0.5% | 76,735 | $998K |
| Lion Point Capital, LP | 5.15% | No change | 62,000 | $807K |
| MYDA Advisors LLC | 0.24% | Add +4.0% | 52,000 | $677K |
| Goldman Sachs Group Inc. | 0.00% | New | 45,883 | $597K |
| Northern Trust Corp. | 0.00% | Add +20.1% | 45,877 | $597K |
| Informed Momentum Co LLC | 0.09% | New | 39,330 | $512K |
| Ameriprise Financial Inc. | 0.00% | Reduce -3.0% | 34,418 | $448K |
| Millennium Management | 0.00% | New | 32,046 | $417K |
| Morgan Stanley | 0.00% | Reduce -37.1% | 26,660 | $347K |
| HRT Financial LP | 0.00% | New | 25,927 | $337K |
| State Street Corp. | 0.00% | Add +31.7% | 21,190 | $276K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -9.1% | 19,003 | $247K |
| UBS Group AG | 0.00% | Add +99.7% | 10,012 | $130K |
| SG Americas Securities, LLC | 0.00% | New | 8,458 | $110K |
| Citigroup Inc. | 0.00% | Reduce -50.6% | 6,155 | $80K |
| GAMMA Investing LLC | 0.01% | Reduce -7.4% | 5,965 | $78K |
| Balyasny Asset Management L.P. | 0.00% | New | 2,816 | $37K |
| Acadian Asset Management LLC | 0.00% | New | 1,817 | $23K |
| Bank of America Corp. | 0.00% | Add +97.3% | 292 | $4K |
| Royal Bank of Canada | 0.00% | Add +20.2% | 208 | $3K |
| Rhumbline Advisers | 0.00% | No change | 186 | $2K |
| Group One Trading LLC | 0.00% | No change | 89 | $1K |
"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.